Making Expedited Regulatory Pathways Work for Global Drug Development Programs

Article from December 2021 edition of Applied Clinical Trials. Parexel regulatory experts offer top tips for working with regulators on a global scale.

Download PDF

Regulatory & Access Resources

Making Expedited Regulatory Pathways Work for Global Drug Development Programs

Five strategies for meeting the requirements of Project Optimus and improving the chances of approval

EU Orphan Drug Designation – overcoming regulatory challenges

Communicating Value to Providers and Payers

Early planning can help you make the most of expedited regulatory pathways

How biotechs can strengthen their value story with advanced analytics

New endpoints for early-stage cancer are gaining regulatory traction

How emerging biotechs can enter the Chinese market and prosper

What to know about FDA INTERACT meetings

Decentralized trial tools and technologies are here to stay: A regulatory perspective

Maximize the efficiency of regulatory operations with five key competencies

Maximize the efficiency of regulatory operations with five key competencies

Lessons from China and the United States on the use of RWE in regulatory submissions

Can Synthetic / External Control Arms meet regulatory and HTA requirements?

Strategies for External Control Arms

Impending avalanche of regulatory compliance activity: Are you prepared?

Crafting an early genomics strategy in oncology drug development

Preparing for EU-CTR

Five competencies for operational excellence in cell and gene therapy clinical trials

Whitepaper: COVID-19 Vaccination in Cancer Patients

3 ways to reap the benefits of adaptive-trials